1,110
Views
14
CrossRef citations to date
0
Altmetric
Research Papers

Blocking NOTCH pathway can enhance the effect of EGFR inhibitor through targeting CD133+ endometrial cancer cells

, &
Pages 113-119 | Received 13 Apr 2016, Accepted 16 Oct 2016, Published online: 16 Jan 2018

Reference

  • Dong P, Kaneuchi M, Konno Y, Watari H, Sudo S, Sakuragi N. Emerging Therapeutic Biomarkers in Endometrial Cancer. Bio Med Res Int 2013; 2013:1-11; PMID:23819113; https://doi.org/10.1155/2013/130362
  • Nakamura M, Kyo S, Zhang B, Zhang X, Mizumoto Y, Takakura M, Maida Y, Mori N, Hashimoto M, Ohno S, Inoue M. Prognostic impact of CD133 expression as a tumor-initiating cell marker in endometrial cancer. Hum Pathol 2010; 41(11):1516-29; PMID:20800872; https://doi.org/10.1016/j.humpath.2010.05.006
  • Zhao D, Mo Y, Li MT, Zou SW, Cheng ZL, Sun YP, Xiong Y, Guan KL, Lei QY. NOTCH-induced aldehyde dehydrogenase 1A1 deacetylation promotes breast cancer stem cells. J Clin Investig 2014; 124(12):5453-65; PMID:25384215; https://doi.org/10.1172/JCI76611
  • Dean M, Fojo T, Bates S. Tumor stem cells and drug resistance. Nat Rev Cancer. 2005; 5 (4): 275-84; PMID:15803154; https://doi.org/10.1038/nrc1590
  • Friel AM, Zhang L, Curley MD, Therrien VA, Sergent PA, Belden SE, Borger DR, Mohapatra G, Zukerberg LR, Foster R, Rueda BR. Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells. Reproductive Biol Endocrinol 2010; 8:147-60; PMID:21122138; https://doi.org/10.1186/1477-7827-8-147
  • Liu J, Mao Z, Huang J, Xie S, Liu T, Mao Z. Blocking the NOTCH pathway can inhibit the growth of CD133-positive A549 cells and sensitize to chemotherapy. Biochem Biophys Res Commun 2014;444(4):670-5; PMID:24502949; https://doi.org/10.1016/j.bbrc.2014.01.164
  • Grenman R1, Burk D, Virolainen E, Buick RN, Church J, Schwartz DR, Carey TE. Clonogenic cell assay for anchorage-dependent squamous carcinoma cell lines using limiting dilution. Int J Cancer 1989; 44(1):131-6; PMID:2744882; https://doi.org/10.1002/ijc.2910440123
  • Ferrandina G1, Bonanno G, Pierelli L, Perillo A, Procoli A, Mariotti A, Corallo M, Martinelli E, Rutella S, Paglia A, et al. Expression of CD133-1 and CD133-2 in ovarian cancer. Int J Gynecol Cancer 2008; 18(3):506-14; PMID:17868344; https://doi.org/10.1111/j.1525-1438.2007.01056.x
  • Fu WN, Guo Y, Huang DF, Shang C, Sun KL. Novel partners of S100A8 identified in laryngeal cancer cell lines. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2007; 24(3): 266-70; PMID:17557234
  • Pardal R, Clarke MF, Morrison SJ. Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 2003; 3(12):895-902; PMID:14737120; https://doi.org/10.1038/nrc1232
  • Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003; 100(7):3983-8; PMID:12629218; https://doi.org/10.1073/pnas.0530291100
  • Hubbard SA, Friel AM, Kumar B, Zhang L, Rueda BR, Gargett CE. Evidence for cancer stem cells in human endometrial carcinoma. Cancer Res 2009; 69(21):8241-8; PMID:19843861; https://doi.org/10.1158/0008-5472.CAN-08-4808
  • Besançon R, Valsesia-Wittmann S, Puisieux A, Caron de Fromentel C, Maguer-Satta V. Cancer stem cells: the emerging challenge of drug targeting. Curr Med Chem 2009; 16(4):394-416; PMID:19199913;https://doi.org/10.2174/092986709787315531
  • Zhou J, Zhang Y. Preclinical development of cancer stem cell drugs. Expert Opin Dryg Discov 2009; 4(7):741-52; PMID:23489167; https://doi.org/10.1517/17460440903002059
  • Nadal R1, Ortega FG, Salido M, Lorente JA, Rodríguez-Rivera M, Delgado-Rodríguez M, Macià M, Fernández A, Corominas JM, García-Puche JL, et al. CD133 expression in circulating tumor cells from breast cancer patients: potential role in resistance to chemotherapy. Int J Cancer 2013; 133(10):2398-407; PMID:23661576; https://doi.org/10.1002/ijc.28263
  • Liu J, Mao Z, Huang J, Xie S, Liu T, Mao Z. Blocking the Notch Pathways can inhibit the growth of CD133- positive A549 cells and sensitize to chemotherapy. Biochem Biophys Res Commun 2014; 444(4):670-5; PMID:24502949; https://doi.org/10.1016/j.bbrc.2014.01.164
  • Mitsuhashi Y1, Horiuchi A, Miyamoto T, Kashima H, Suzuki A, Shiozawa T. Prognostic significance of Notch signalling molecules and their involvement in the invasiveness of endometrial carcinoma cells. Histopathology 2012; 60(5):826-37; PMID:22348356; https://doi.org/10.1111/j.1365-2559.2011.04158.x
  • Chen Y1, Li D, Liu H, Xu H, Zheng H, Qian F, Li W, Zhao C, Wang Z, Wang X. Notch-1 signaling facilitates survivin expression in human non-small cell lung cancercells. Cancer Biol Ther 2011; 11(1):14-21; PMID:20962575; https://doi.org/10.4161/cbt.11.1.13730
  • Sasnauskienė A, Jonušienė V, Krikštaponienė A, Butkytė S, Dabkevičienė D, Kanopienė D, Kazbarienė B, Didžiapetrienė J. NOTCH1, NOTCH3, NOTCH4 and JAG2 protein levels in humanendometrial cancer. Medicina (Kaunas) 2014; 50(1):14-8; PMID:25060200; https://doi.org/10.1016/j.medici.2014.05.002
  • Ji X, Wang Z, Geamanu A, Sarkar FH, Gupta SV. Inhibition of cell growth and induction of apoptosis in non-small cell lung cancer cells by delta-tocotrienol is associated with notch-1 down-regulation. J Cell Biochem 2011; 112(10):2773-83; PMID:21598300; https://doi.org/10.1002/jcb.23184
  • Jonusiene V1, Sasnauskiene A, Lachej N, Kanopiene D, Dabkeviciene D, Sasnauskiene S, Kazbariene B, Didziapetriene J. Down-regulated expression of Notch signaling molecules in human endometrial cancer. Med Oncol 2013; 30(1):438; PMID:23315219; https://doi.org/10.1007/s12032-012-0438-y

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.